Bxcl501
Deep Brain Stimulation
Beijing Tiantan HospitalPhase 4 / ApprovedActive
BB
65/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 50/ 100
- Competitive Position
- 89/ 100
Competitive context
10 Active assets in the Deep Brain Stimulation cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Posiphen Annovis Bio Inc. | Phase 2/3 | B |
Phenserine Annovis Bio Inc. | Phase 2/3 | B |
CISATRACURIUM ION Beijing Tiantan Hospital | N/A | D |
S-Ketamine Beijing Tiantan Hospital | N/A | D |
SUFENTANIL CITRATE Beijing Tiantan Hospital | N/A | D |
View all 10 →
Same molecule, other indications
Bxcl501 is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →